Acadia Pharmaceuticals Stock Analysis
| ACAD Stock | USD 22.37 0.33 1.45% |
ACADIA Pharmaceuticals is undervalued with Real Value of 26.03 and Hype Value of 22.72. The main objective of ACADIA Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what ACADIA Pharmaceuticals is worth, separate from its market price. There are two main types of ACADIA Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The ACADIA Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and ACADIA Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ACADIA Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. ACADIA Stock Analysis Notes
About 99.0% of the company shares are held by institutions such as insurance companies. The book value of ACADIA Pharmaceuticals was presently reported as 4.88. The company last dividend was issued on the 30th of June 2010. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California. Acadia Pharmaceutica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 540 people. For more info on ACADIA Pharmaceuticals please contact Stephen JD at 858 558 2871 or go to https://www.acadia.com.ACADIA Pharmaceuticals Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ACADIA Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding ACADIA Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| ACADIA Pharmaceuticals generated a negative expected return over the last 90 days | |
| ACADIA Pharmaceuticals has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are held by institutions such as insurance companies |
ACADIA Pharmaceuticals Upcoming and Recent Events
| 26th of February 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
ACADIA Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.83 B.ACADIA Profitablity
The company has Profit Margin (PM) of 0.22 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.12 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.12.Technical Drivers
As of the 3rd of November, ACADIA Pharmaceuticals owns the variance of 6.04, and Market Risk Adjusted Performance of 0.3153. ACADIA Pharmaceuticals technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the entity's future prices. Please confirm ACADIA Pharmaceuticals information ratio, potential upside, and the relationship between the standard deviation and maximum drawdown to decide if ACADIA Pharmaceuticals is priced adequately, providing market reflects its prevailing price of 22.37 per share. Given that ACADIA Pharmaceuticals has information ratio of (0.07), we suggest you to validate ACADIA Pharmaceuticals's latest market performance to make sure the company can sustain itself at some future date.ACADIA Pharmaceuticals Price Movement Analysis
The output start index for this execution was eight with a total number of output elements of fifty-three. The Moving Average is predictive technique used to analyze ACADIA Pharmaceuticals price data points by creating a series of averages of different subsets of ACADIA Pharmaceuticals entire price series.
ACADIA Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ACADIA Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on ACADIA Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ACADIA Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ACADIA Pharmaceuticals Outstanding Bonds
ACADIA Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ACADIA Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ACADIA bonds can be classified according to their maturity, which is the date when ACADIA Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
ACADIA Pharmaceuticals Predictive Daily Indicators
ACADIA Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ACADIA Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 72538.31 | |||
| Daily Balance Of Power | (0.36) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 22.33 | |||
| Day Typical Price | 22.34 | |||
| Price Action Indicator | (0.12) | |||
| Period Momentum Indicator | (0.33) | |||
| Relative Strength Index | 21.65 |
ACADIA Pharmaceuticals Forecast Models
ACADIA Pharmaceuticals' time-series forecasting models are one of many ACADIA Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ACADIA Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About ACADIA Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how ACADIA Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ACADIA shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ACADIA Pharmaceuticals. By using and applying ACADIA Stock analysis, traders can create a robust methodology for identifying ACADIA entry and exit points for their positions.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California. Acadia Pharmaceutica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 540 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ACADIA Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Complementary Tools for ACADIA Stock analysis
When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets |